The global demand for Endoscopic Retrograde Cholangiopancreatography Market is presumed to reach the market size of nearly USD 4.7 BN by 2030 from USD 2.13 BN in 2022 with a CAGR of 10.42% under the study period 2023 - 2030.
Endoscopic retrograde cholangio pancreatography refers to the clinical procedure used for the diagnosis and treatment of the liver, ball ducts and pancreas etc. It is a minimally invasive intervention procedure which combines upper gastrointestinal endoscopy and x-rays for the treatment of different gastrointestinal conditions. During endoscopic retrograde cholangio pancreatography, the doctor locates the opening of bile pancreas ducts where it empties into the duodenum, slides a catheter into the ducts, inserts a contrast medium into the ducts for more visibility of the ducts and uses fluoroscopy for the examination of blockages. But, there can be bloating and nausea after the procedure.
The rising cancer cases is the main factor driving the demand for the endoscopic retrograde cholangio pancreatography market. The rise in the generic population, along with the growing prevalence of biliary disorders, is surging the demand for this market. The increasing development of healthcare infrastructure in developing countries is propelling the demand for this market. Moreover, the rising preference for minimally invasive surgeries is upsurging the demand for the endoscopic retrograde cholangio pancreatography market. Rising cases of pancreatic duct and bile duct stones are augmenting the demand for this market. Furthermore, increasing government initiative and rising investment by healthcare organizations to enhance endoscopy research is expanding the demand for this market. The growth in medical tourism is boosting the demand for this market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of endoscopic retrograde cholangiopancreatography. The growth and trends of endoscopic retrograde cholangiopancreatography industry provide a holistic approach to this study.
This section of the endoscopic retrograde cholangiopancreatography market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
By Application
By End User
This section covers the regional outlook, which accentuates current and future demand for the Endoscopic Retrograde Cholangiopancreatography market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the endoscopic retrograde cholangiopancreatography market include Olympus Corporation, Conmed Corporation, Hobbs Medical, Inc., TeleMed Systems, Inc., Boston Scientific Corporation, Cook Group Incorporation, Ambu, Inc., Becton, Dickinson and Company, Fujifilm Holding Corporation, and Medtronic Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Avail customized purchase options to meet your exact research needs: